The availability of CCR1- and CCR5-specific inhibitors enabled researchers to test relative involvement of the main CCL3 receptors in MM bone metastasis using the 5TMM experimental myeloma mouse model which is thought to recapitulate the human disease in several key aspects (68). This evidence concerns the gene CCR1 and Miyoshi myopathy.